{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:08:28Z","timestamp":1790168908284,"version":"4.1.0"},"reference-count":58,"publisher":"MJS Publishing, Medical Journals Sweden AB","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Derm Venereol"],"abstract":"<jats:p>Actinic keratosis (AK) is a precancerous condition typically diagnosed by hyperkeratotic papules. The concept of field cancerization suggests subclinical lesions surround visible\u00a0actinic keratoses. Photodynamic diagnosis (PDD)is a non-invasive imaging modality that can im-prove\u00a0actinic keratosis diagnosis and treatment assessment. This systematic review describes current evidence regarding\u00a0photodynamic diagnosis modalities for\u00a0actinic keratosis. We searched MEDLINE and Embase through 28 February, 2025. Data synthesis was descriptive due to methodological heterogeneity across studies. Thirty-seven studies were included. Methyl aminolevulinate(MAL) and aminolevulinic acid (ALA)were used in 54% and 51% of studies, respectively. Incubation times ranged from 20 to 1080 min, 70 % of studies followed a 3 -h protocol. Most excitation sources (89%) emitted light within the 400\u2013410 nm range, often via clinical-grade systems (54%). Imaging hardware varied: 54 % used integrated clinical systems, 30 % used independent cameras. Fluorescence quantification was described in 62 % of studies, and 54 % used specialized analysis software. Patient positioning was rarely reported (8%). This review highlights significant methodological heterogeneity in\u00a0actinic keratosis\u00a0photodynamic diagnosis, particularly in photosensitizer protocols and imaging systems. While clinical-grade systems provide standardization, low-cost alternatives enhance accessibility. However, lack of procedural consistency limits comparability. Future efforts should focus on advancing standardized protocols to support broader clinical validation and adoption.<\/jats:p>","DOI":"10.2340\/actadv.v106.adv-2026-0949","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:52:38Z","timestamp":1790167958000},"source":"Crossref","is-referenced-by-count":0,"title":["Photodynamic Diagnosis of Actinic Keratosis: A Systematic Review"],"prefix":"10.2340","volume":"106","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-5328-3192","authenticated-orcid":false,"given":"Younes","family":"Kazbennaou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Boileau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Maire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadira","family":"Delhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Sophie","family":"Dewalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Mortier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1183","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"169112","doi-asserted-by":"crossref","unstructured":"Moy RL. Clinical presentation of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol 2000; 42: 8\u201310.","DOI":"10.1067\/mjd.2000.103343"},{"key":"169113","doi-asserted-by":"crossref","unstructured":"Khanna R, Bakshi A, Amir Y, Goldenberg G. Patient satisfaction and reported outcomes on the management of actinic keratosis. Clin Cosmet Investig Dermatol 2017; 10: 179\u2013184.","DOI":"10.2147\/CCID.S121323"},{"key":"169114","doi-asserted-by":"crossref","unstructured":"Richard MA, Amici JM, Basset-Seguin N, Claudel JP, Cribier B, Dreno B. Management of actinic keratosis at specific body sites in patients at high risk of carcinoma lesions: expert consensus from the AKTeamTM of expert clinicians. J Eur Acad Dermatol Venereol 2018; 32: 339\u2013346.","DOI":"10.1111\/jdv.14753"},{"key":"169115","doi-asserted-by":"crossref","unstructured":"Rosen T, Lebwohl MG. Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol 2013; 68: S2\u20139.","DOI":"10.1016\/j.jaad.2012.09.052"},{"key":"169116","doi-asserted-by":"crossref","unstructured":"Flohil SC, van der Leest RJT, Dowlatshahi EA, Hofman A, de Vries E, Nijsten T. Prevalence of actinic keratosis and its risk factors in the general population: the Rotterdam Study. J Invest Dermatol 2013; 133: 1971\u20131978.","DOI":"10.1038\/jid.2013.134"},{"key":"169117","doi-asserted-by":"crossref","unstructured":"Euvrard S, Kanitakis J, Pouteil-Noble C, Dureau G, Touraine JL, Faure M, et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33: 222\u2013229.","DOI":"10.1016\/0190-9622(95)90239-2"},{"key":"169118","doi-asserted-by":"crossref","unstructured":"Malvehy J. A new vision of actinic keratosis beyond visible clinical lesions. J Eur Acad Dermatol Venereol 2015; 29 Suppl 1: 3\u20138.","DOI":"10.1111\/jdv.12833"},{"key":"169119","doi-asserted-by":"crossref","unstructured":"Willenbrink TJ, Ruiz ES, Cornejo CM, Schmults CD, Arron ST, Jambusaria-Pahlajani A. Field cancerization: definition, epidemiology, risk factors, and outcomes. J Am Acad Dermatol 2020; 83: 709\u2013717.","DOI":"10.1016\/j.jaad.2020.03.126"},{"key":"169120","doi-asserted-by":"crossref","unstructured":"Glogau RG. The risk of progression to invasive disease. J Am Acad Dermatol 2000; 42: 23\u201324.","DOI":"10.1067\/mjd.2000.103339"},{"key":"169121","doi-asserted-by":"crossref","unstructured":"Marks R, Rennie G, Selwood Thomas S. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet 1988; 331: 795\u2013797.","DOI":"10.1016\/S0140-6736(88)91658-3"},{"key":"169122","doi-asserted-by":"crossref","unstructured":"Huerta-Brogeras M, Olmos O, Borbujo J, Hern\u00e1ndez-N\u00fa\u00f1ez A, Casta\u00f1o E, Romero-Mat\u00e9 A, et al. Validation of dermoscopy as a real-time noninvasive diagnostic imaging technique for actinic keratosis. Arch Dermatol 2012; 148: 1159\u20131164.","DOI":"10.1001\/archdermatol.2012.1060"},{"key":"169123","doi-asserted-by":"crossref","unstructured":"Ulrich M, Maltusch A, Rius-Diaz F, R\u00f6wert-Huber J, Gonz\u00e1lez S, Sterry W, et al. Clinical applicability of in vivo reflectance confocal microscopy for the diagnosis of actinic keratoses. Dermatol Surg 2008; 34: 610\u2013619.","DOI":"10.1111\/j.1524-4725.2007.34117.x"},{"key":"169124","doi-asserted-by":"crossref","unstructured":"Ulrich M, Krueger-Corcoran D, Roewert-Huber J, Sterry W, Stockfleth E, Astner S. Reflectance confocal microscopy for noninvasive monitoring of therapy and detection of subclinical actinic keratoses. Dermatology 2010; 220: 15\u201324.","DOI":"10.1159\/000254893"},{"key":"169125","doi-asserted-by":"crossref","unstructured":"Maier T, Braun-Falco M, Laubender RP, Ruzicka T, Berking C. Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology. Br J Dermatol 2013; 168: 120\u2013128.","DOI":"10.1111\/j.1365-2133.2012.11202.x"},{"key":"169126","doi-asserted-by":"crossref","unstructured":"Boone MALM, Norrenberg S, Jemec GBE, Del Marmol V. Imaging actinic keratosis by high-definition optical coherence tomography. Histomorphologic correlation: a pilot study. Exp Dermatol 2013; 22: 93\u201397.","DOI":"10.1111\/exd.12074"},{"key":"169127","doi-asserted-by":"crossref","unstructured":"Ogien J, Tavernier C, Fischman S, Dubois A. Line-field confocal optical coherence tomography (LC-OCT): principles and practical use. Ital J Dermatol Venerol 2023; 158: 171\u2013179.","DOI":"10.23736\/S2784-8671.23.07613-2"},{"key":"169128","doi-asserted-by":"crossref","unstructured":"Lacarrubba F, Verz\u00ec AE, Polita M, Aleo A, Micali G. Line\u2010field confocal optical coherence tomography in the treatment monitoring of actinic keratosis with tirbanibulin: a pilot study. Acad Dermatol Venereol 2023; 37: e1131\u20133.","DOI":"10.1111\/jdv.19147"},{"key":"169129","doi-asserted-by":"crossref","unstructured":"Yang X, Palasuberniam P, Kraus D, Chen B. Aminolevulinic acid-based tumor detection and therapy: molecular mechanisms and strategies for enhancement. IJMS 2015; 16: 25865\u201325880.","DOI":"10.3390\/ijms161025865"},{"key":"169130","doi-asserted-by":"crossref","unstructured":"Blume JE, Oseroff AR. Aminolevulinic acid photodynamic therapy for skin cancers. Dermatol Clin 2007; 25: 5\u201314.","DOI":"10.1016\/j.det.2006.09.005"},{"key":"169131","doi-asserted-by":"crossref","unstructured":"Ortonne JP, Gupta G, Ortonne N, Duteil L, Queille C, Mallefet P. Effectiveness of cross polarized light and fluorescence diagnosis for detection of sub\u2010clinical and clinical actinic keratosis during imiquimod treatment. Exp Dermatol 2010; 19: 641\u2013647.","DOI":"10.1111\/j.1600-0625.2009.01047.x"},{"key":"169132","doi-asserted-by":"crossref","unstructured":"Braathen LR, Morton CA, Basset\u2010Seguin N, Bissonnette R, Gerritsen MJP, Gilaberte Y, et al. Photodynamic therapy for skin field cancerization: an international consensus. International Society for Photodynamic Therapy in Dermatology. Acad Dermatol Venereol 2012; 26: 1063\u20131066.","DOI":"10.1111\/j.1468-3083.2011.04432.x"},{"key":"169133","doi-asserted-by":"crossref","unstructured":"Zeitouni NC, Schlesinger T, Kheterpal M, Jolly PS, Jagdeo J. 5-aminolevulinic acid photodynamic therapy for the treatment of basal and squamous cell carcinoma: a systematic review. Photodiagnosis Photodyn Ther 2025; 54: 104649.","DOI":"10.1016\/j.pdpdt.2025.104649"},{"key":"169134","unstructured":"Kennedy JC, Pottier RH. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B 1992; 14: 275\u2013292."},{"key":"169135","doi-asserted-by":"crossref","unstructured":"Jeffes EW, McCullough JL, Weinstein GD, Fergin PE, Nelson JS, Shull TF, et al. Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. Arch Dermatol 1997; 133: 727\u2013732.","DOI":"10.1001\/archderm.1997.03890420065007"},{"key":"169136","doi-asserted-by":"crossref","unstructured":"Piffaretti F, Zellweger M, Kasraee B, Barge J, Salomon D, van den Bergh H, et al. Correlation between protoporphyrin IX fluorescence intensity, photobleaching, pain and clinical outcome of actinic keratosis treated by photodynamic therapy. Dermatology 2013; 227: 214\u2013225.","DOI":"10.1159\/000353775"},{"key":"169137","doi-asserted-by":"crossref","unstructured":"van der Beek N, de Leeuw J, Demmendal C, Bjerring P, Neumann HAM. PpIX fluorescence combined with auto-fluorescence is more accurate than PpIX fluorescence alone in fluorescence detection of non-melanoma skin cancer: an intra-patient direct comparison study. Lasers Surg Med 2012; 44: 271\u2013276.","DOI":"10.1002\/lsm.21134"},{"key":"169138","doi-asserted-by":"crossref","unstructured":"Wiegell SR, Petersen B, Wulf HC. Pulse photodynamic therapy reduces inflammation without compromising efficacy in the treatment of multiple mild actinic keratoses of the face and scalp: a randomized clinical trial. Br J Dermatol 2016; 174: 979\u2013984.","DOI":"10.1111\/bjd.14465"},{"key":"169139","doi-asserted-by":"crossref","unstructured":"Smits T, Kleinpenning MM, Blokx WAM, van de Kerkhof PCM, van Erp PEJ, Gerritsen MJP. Fluorescence diagnosis in keratinocytic intraepidermal neoplasias. J Am Acad Dermatol 2007; 57: 824\u2013831.","DOI":"10.1016\/j.jaad.2007.06.031"},{"key":"169140","doi-asserted-by":"crossref","unstructured":"Rossi A, Garelli V, Pranteda G, Cardone M, Anzalone A, Fortuna MC, et al. Dermoscopy and methyl aminolevulinate: A study for detection and evaluation of field cancerization. J Photochem Photobiol B 2016; 162: 72\u201376.","DOI":"10.1016\/j.jphotobiol.2016.06.028"},{"key":"169141","doi-asserted-by":"crossref","unstructured":"de Leeuw J, van der Beek N, Neugebauer WD, Bjerring P, Neumann HAM. Fluorescence detection and diagnosis of non-melanoma skin cancer at an early stage. Lasers Surg Med 2009; 41: 96\u2013103.","DOI":"10.1002\/lsm.20739"},{"key":"169142","doi-asserted-by":"crossref","unstructured":"Tyrrell J, Campbell SM, Curnow A. Monitoring the accumulation and dissipation of the photosensitizer protoporphyrin IX during standard dermatological methyl-aminolevulinate photodynamic therapy utilizing non-invasive fluorescence imaging and quantification. Photodiagnosis Photodyn Ther 2011; 8: 30\u201338.","DOI":"10.1016\/j.pdpdt.2010.11.001"},{"key":"169143","doi-asserted-by":"crossref","unstructured":"Bobyr I, Campanati A, Giacchetti A, Offidani A. Fluorescent photodiagnostic evaluation of field cancerization treated with a medical device containing piroxicam 0.8% and sunscreen SPF 50+ for actinic keratosis. Photoderm Photoimm Photomed 2019; 35: 277\u2013279.","DOI":"10.1111\/phpp.12452"},{"key":"169144","doi-asserted-by":"crossref","unstructured":"Tyrrell J, Campbell S, Curnow A. Validation of a non-invasive fluorescence imaging system to monitor dermatological PDT. Photodiagnosis Photodyn Ther 2010; 7: 86\u201397.","DOI":"10.1016\/j.pdpdt.2010.03.002"},{"key":"169145","doi-asserted-by":"crossref","unstructured":"Sorbellini E, Marzani B, Pinto D, Rinaldi F. Actinic keratosis prevention \u2013 A double-blind, half-face interventional study with a topical treatment. JST 2018; 9: 1.","DOI":"10.5430\/jst.v9n1p1"},{"key":"169146","doi-asserted-by":"crossref","unstructured":"Bartosi\u0144ska J, Szczepanik-Ku\u0142ak P, Raczkiewicz D, Niewiedzio\u0142 M, Gerkowicz A, Kowalczuk D, et al. Topical photodynamic therapy with different forms of 5-aminolevulinic acid in the treatment of actinic keratosis. Pharmaceutics 2022; 14: 346.","DOI":"10.3390\/pharmaceutics14020346"},{"key":"169147","doi-asserted-by":"crossref","unstructured":"Tyrrell J, Paterson C, Curnow A. Regression analysis of protoporphyrin IX measurements obtained during dermatological photodynamic therapy. Cancers 2019; 11: 72.","DOI":"10.3390\/cancers11010072"},{"key":"169148","doi-asserted-by":"crossref","unstructured":"Kim BK, Lee NR, Park SY, Eom M, Choi EH. Efficacy of photodynamic therapy with laser pretreatment for actinic keratosis and photorejuvenation as evaluated by fluorescent imaging. Photoderm Photoimm Photomed 2015; 31: 36\u201343.","DOI":"10.1111\/phpp.12140"},{"key":"169149","doi-asserted-by":"crossref","unstructured":"Korecka K, Pola\u0144ska A, Da\u0144czak-Pazdrowska A, Navarrete-Dechent C. Assessing field cancerization and actinic keratosis using ultraviolet-induced fluorescence dermatoscopy after the application of 5-aminolevulinic acid - an observational study. Photodiagnosis Photodyn Ther 2024; 46: 104056.","DOI":"10.1016\/j.pdpdt.2024.104056"},{"key":"169150","doi-asserted-by":"crossref","unstructured":"Jeffes EW, McCullough JL, Weinstein GD, Kaplan R, Glazer SD, Taylor JR. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol 2001; 45: 96\u2013104.","DOI":"10.1067\/mjd.2001.114288"},{"key":"169151","doi-asserted-by":"crossref","unstructured":"Togsverd-Bo K, Haak CS, Thaysen-Petersen D, Wulf HC, Anderson RR, H\u00e6dersdal M. Intensified photodynamic therapy of actinic keratoses with fractional CO2 laser: a randomized clinical trial. Br J Dermatol 2012; 166: 1262\u20131269.","DOI":"10.1111\/j.1365-2133.2012.10893.x"},{"key":"169152","doi-asserted-by":"crossref","unstructured":"Ericson MB, Sandberg C, Stenquist B, Gudmundson F, Karlsson M, Ros AM, et al. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome. Br J Dermatol 2004; 151: 1204\u20131212.","DOI":"10.1111\/j.1365-2133.2004.06211.x"},{"key":"169153","doi-asserted-by":"crossref","unstructured":"Li L, Li Y, Dong H, Yan J, Zhang Y, Zhang C, et al. Therapeutic and fluorescence evaluation of 20% 5-aminolevulinic acid-mediated photodynamic therapy in actinic keratosis. Photodiagnosis Photodyn Ther 2024; 47: 104100.","DOI":"10.1016\/j.pdpdt.2024.104100"},{"key":"169154","doi-asserted-by":"crossref","unstructured":"Willey A. Thermal photodynamic therapy for actinic keratoses on facial skin: a proof-of-concept study. Dermatol Surg 2019; 45: 404\u2013410.","DOI":"10.1097\/DSS.0000000000001702"},{"key":"169155","doi-asserted-by":"crossref","unstructured":"Petersen B, Wiegell SR, Wulf HC. Light protection of the skin after photodynamic therapy reduces inflammation: an unblinded randomized controlled study. Br J Dermatol 2014; 171: 175\u2013178.","DOI":"10.1111\/bjd.12882"},{"key":"169156","doi-asserted-by":"crossref","unstructured":"Tyrrell JS, Campbell SM, Curnow A. The relationship between protoporphyrin IX photobleaching during real-time dermatological methyl-aminolevulinate photodynamic therapy (MAL-PDT) and subsequent clinical outcome. Lasers Surg Med 2010; 42: 613\u2013619.","DOI":"10.1002\/lsm.20943"},{"key":"169157","doi-asserted-by":"crossref","unstructured":"Regin Wiegell S, H\u00e6dersdal M, Christian Wulf H. Cold water and pauses in illumination reduces pain during photodynamic therapy: a randomized clinical study. Acta Derm Venereol 2009; 89: 145\u2013149.","DOI":"10.2340\/00015555-0568"},{"key":"169158","doi-asserted-by":"crossref","unstructured":"Smits T, Robles CA, van Erp PEJ, van de Kerkhof PCM, Gerritsen MJP. Correlation between macroscopic fluorescence and protoporphyrin IX content in psoriasis and actinic keratosis following application of aminolevulinic acid. J Invest Dermatol 2005; 125: 833\u2013839.","DOI":"10.1111\/j.0022-202X.2005.23843.x"},{"key":"169159","doi-asserted-by":"crossref","unstructured":"Wiegell SR, Petersen B, Wulf HC. Topical corticosteroid reduces inflammation without compromising the efficacy of photodynamic therapy for actinic keratoses: a randomized clinical trial. Br J Dermatol 2014; 171: 1487\u20131492.","DOI":"10.1111\/bjd.13284"},{"key":"169160","doi-asserted-by":"crossref","unstructured":"Buinauskaite E, Zalinkevicius R, Buinauskiene J, Valiukeviciene S. Pain during topical photodynamic therapy of actinic keratoses with 5\u2010aminolevulinic acid and red light source: randomized controlled trial. Photoderm Photoimm Photomed 2013; 29: 173\u2013181.","DOI":"10.1111\/phpp.12044"},{"key":"169161","doi-asserted-by":"crossref","unstructured":"Fauteck JD, Ackermann G, Birkel M, Breuer M, Moor ACE, Ebeling A, et al. Fluorescence characteristics and pharmacokinetic properties of a novel self-adhesive 5-ALA patch for photodynamic therapy of actinic keratoses. Arch Dermatol Res 2008; 300: 53\u201360.","DOI":"10.1007\/s00403-007-0787-0"},{"key":"169162","doi-asserted-by":"crossref","unstructured":"Wiegell SR, Skiveren J, Philipsen PA, Wulf HC. Pain during photodynamic therapy is associated with protoporphyrin IX fluorescence and fluence rate. Br J Dermatol 2008; 158: 727\u2013733.","DOI":"10.1111\/j.1365-2133.2008.08451.x"},{"key":"169163","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Guarino M, Mavura D, Fern\u00e1ndez-Gonz\u00e1lez P, Chapa P, Ravazzano C, Ja\u00e9n L, et al. Daylight photodynamic therapy is an option for the treatment of actinic keratosis in patients with xeroderma pigmentosum in Africa. Photodiagnosis Photodyn Ther 2020; 29: 101631.","DOI":"10.1016\/j.pdpdt.2019.101631"},{"key":"169164","doi-asserted-by":"crossref","unstructured":"Kulyk O, Ibbotson SH, Moseley H, Valentine RM, Samuel IDW. Development of a handheld fluorescence imaging device to investigate the characteristics of protoporphyrin IX fluorescence in healthy and diseased skin. Photodiagnosis Photodyn Ther 2015; 12: 630\u2013639.","DOI":"10.1016\/j.pdpdt.2015.10.002"},{"key":"169165","doi-asserted-by":"crossref","unstructured":"Neittaanm\u00e4ki-Perttu N, Gr\u00f6nroos M, Tani T, P\u00f6l\u00f6nen I, Ranki A, Saksela O, et al. Detecting field cancerization using a hyperspectral imaging system. Lasers Surg Med 2013; 45: 410\u2013417.","DOI":"10.1002\/lsm.22160"},{"key":"169166","doi-asserted-by":"crossref","unstructured":"Blake E, Allen J, Thorn C, Shore A, Curnow A. Effect of an oxygen pressure injection (OPI) device on the oxygen saturation of patients during dermatological methyl aminolevulinate photodynamic therapy. Lasers Med Sci 2013; 28: 997\u20131005.","DOI":"10.1007\/s10103-012-1188-y"},{"key":"169167","unstructured":"Puizina-Ivi\u0107 N, Zorc H, Vanjaka-Rogosi\u0107 L, Miri\u0107 L, Persin A. Fractionated illumination improves the outcome in the treatment of precancerous lesions with photodynamic therapy. Coll Antropol 2008; 32 Suppl 2: 67\u201373."},{"key":"169168","doi-asserted-by":"crossref","unstructured":"Szeimies RM, Landthaler M. Photodynamic therapy and fluorescence diagnosis of skin cancers. Recent Results Cancer Res 2002; 160: 240\u2013245.","DOI":"10.1007\/978-3-642-59410-6_28"},{"key":"169169","doi-asserted-by":"crossref","unstructured":"Siero\u0144 A, Kawczyk-Krupka A, Cebula MAW, Szygu\u0142a M, Ziele\u017cnik W, Gruk M, et al. Photodynamic therapy (PDT) using topically applied \u03b4-aminolevulinic acid (ALA) for the treatment of malignant skin tumors. Photodiagnosis Photodyn Ther 2004; 1: 311\u2013317.","DOI":"10.1016\/S1572-1000(04)00069-9"}],"container-title":["Acta Dermato-Venereologica"],"original-title":[],"link":[{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46927\/55592","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46927\/55593","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46927\/55595","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/download\/46927\/55592","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:52:57Z","timestamp":1790167977000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actadv\/article\/view\/46927"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":58,"URL":"https:\/\/doi.org\/10.2340\/actadv.v106.adv-2026-0949","relation":{},"ISSN":["1651-2057","0001-5555"],"issn-type":[{"value":"1651-2057","type":"electronic"},{"value":"0001-5555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}